| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |